wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38415231-717147C2-071C-4FD1-94B8-BA0077E8043D
Q38415231-717147C2-071C-4FD1-94B8-BA0077E8043D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38415231-717147C2-071C-4FD1-94B8-BA0077E8043D
Emerging PCSK9 inhibitors for treating dyslipidaemia: buttressing the gaps in coronary prevention.
P2860
Q38415231-717147C2-071C-4FD1-94B8-BA0077E8043D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38415231-717147C2-071C-4FD1-94B8-BA0077E8043D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3a1797a6d3d2c24e936215b9afd98dc60bf398c5
P2860
Effect of alirocumab, a monoclonal proprotein convertase subtilisin/kexin 9 antibody, on lipoprotein(a) concentrations (a pooled analysis of 150 mg every two weeks dosing from phase 2 trials).